| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
77,921,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
4,773,204 |
Avg
Vol: |
2,204,032 |
| 52
Week Range: |
$81.49 - $81.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
• – – |
2009-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
63,652 |
|
- |
|
| Roche Robert P Jr |
EVP, WW Pharm Ops |
• – – |
2008-12-22 |
4 |
S |
$77.00 |
$1,845,823 |
D/D |
(23,920) |
41,221 |
|
- |
|
| Roche Robert P Jr |
EVP, WW Pharm Ops |
• – – |
2008-12-22 |
4 |
OE |
$48.06 |
$918,452 |
D/D |
18,319 |
65,141 |
|
- |
|
| Roche Robert P Jr |
EVP, WW Pharm Ops |
• – – |
2008-12-22 |
4 |
D |
$77.16 |
$139,505 |
D/D |
(1,808) |
46,822 |
|
- |
|
| Vaught Jeffry L |
Exec. V.P., Chief Scientific |
• – – |
2008-12-19 |
4 |
D |
$77.50 |
$116,483 |
D/D |
(1,503) |
57,068 |
|
- |
|
| Russell Lesley |
Exec. V.P., Chief Medical |
• – – |
2008-12-19 |
4 |
D |
$77.50 |
$117,955 |
D/D |
(1,522) |
42,094 |
|
- |
|
| Savini Carl A |
EVP,Chief Admin. Off. |
• – – |
2008-12-19 |
4 |
D |
$77.50 |
$117,955 |
D/D |
(1,522) |
60,060 |
|
- |
|
| Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
• – – |
2008-12-19 |
4 |
D |
$77.50 |
$117,955 |
D/D |
(1,522) |
60,003 |
|
- |
|
| Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
• – – |
2008-12-19 |
4 |
D |
$77.50 |
$116,483 |
D/D |
(1,503) |
48,895 |
|
- |
|
| Buchi J Kevin |
Exec. V.P., CFO |
• – – |
2008-12-19 |
4 |
D |
$77.50 |
$125,240 |
D/D |
(1,616) |
75,796 |
|
- |
|
| Baldino Frank Jr |
Chairman and CEO |
• • – |
2008-12-19 |
4 |
D |
$77.50 |
$621,705 |
D/D |
(8,022) |
479,811 |
|
- |
|
| Roche Robert P Jr |
EVP, WW Pharm Ops |
• – – |
2008-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
34 |
48,630 |
|
- |
|
| Buchi J Kevin |
EVP & CFO |
• – – |
2008-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
35 |
75,656 |
|
- |
|
| Roche Robert P Jr |
EVP, WW Pharm Ops |
• – – |
2008-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
231 |
48,664 |
|
- |
|
| Buchi J Kevin |
EVP & CFO |
• – – |
2008-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
105 |
75,691 |
|
- |
|
| Vaught Jeffry L |
Exec. V.P., Chief Scientific |
• – – |
2008-12-16 |
4 |
D |
$76.35 |
$137,735 |
D/D |
(1,804) |
58,571 |
|
- |
|
| Savini Carl A |
EVP,Chief Admin. Off. |
• – – |
2008-12-16 |
4 |
D |
$76.35 |
$139,491 |
D/D |
(1,827) |
61,582 |
|
- |
|
| Russell Lesley |
Exec. V.P., Chief Medical |
• – – |
2008-12-16 |
4 |
D |
$76.35 |
$12,445 |
D/D |
(163) |
43,616 |
|
- |
|
| Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
• – – |
2008-12-16 |
4 |
D |
$76.35 |
$137,735 |
D/D |
(1,804) |
50,398 |
|
- |
|
| Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
• – – |
2008-12-16 |
4 |
D |
$76.35 |
$139,491 |
D/D |
(1,827) |
61,525 |
|
- |
|
| Buchi J Kevin |
Exec. V.P., CFO |
• – – |
2008-12-16 |
4 |
D |
$76.35 |
$148,043 |
D/D |
(1,939) |
77,412 |
|
- |
|
| Baldino Frank Jr |
Chairman and CEO |
• • – |
2008-12-16 |
4 |
D |
$76.35 |
$689,059 |
D/D |
(9,025) |
487,833 |
|
- |
|
| Vaught Jeffry L |
Exec. V.P., Chief Scientific |
• – – |
2008-12-15 |
4 |
D |
$75.29 |
$113,161 |
D/D |
(1,503) |
60,375 |
|
- |
|
| Savini Carl A |
EVP,Chief Admin. Off. |
• – – |
2008-12-15 |
4 |
D |
$75.29 |
$114,591 |
D/D |
(1,522) |
63,409 |
|
- |
|
| Russell Lesley |
Exec. V.P., Chief Medical |
• – – |
2008-12-15 |
4 |
D |
$75.29 |
$114,591 |
D/D |
(1,522) |
43,779 |
|
- |
|
491 Records found
|
|
Page 6 of 20 |
|
|
